2012
DOI: 10.1007/s10840-012-9744-8
|View full text |Cite
|
Sign up to set email alerts
|

Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation

Abstract: There was a comparable and significant improvement in QoL post-ablation in patients who underwent ablation using PVAC catheter and conventional techniques.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
14
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 39 publications
1
14
0
Order By: Relevance
“…On the other hand, nMARQ ® significantly increased the procedure time in the study of Wakili [24]. There was also a statistically significant reduction in total fluoroscopy time in most of the studies except for the studies by Beukema, Tivig (persistent AF subgroup), Looi, De Greef, Gal, and Rosso that no significant difference on total fluoroscopy times was observed between the 2 ablation strategies [12], [14], [15], [18], [20], [22]. Similar to procedure time, nMARQ ® significantly increased the fluoroscopy time in the study of Wakili [24].…”
Section: Resultsmentioning
confidence: 81%
See 3 more Smart Citations
“…On the other hand, nMARQ ® significantly increased the procedure time in the study of Wakili [24]. There was also a statistically significant reduction in total fluoroscopy time in most of the studies except for the studies by Beukema, Tivig (persistent AF subgroup), Looi, De Greef, Gal, and Rosso that no significant difference on total fluoroscopy times was observed between the 2 ablation strategies [12], [14], [15], [18], [20], [22]. Similar to procedure time, nMARQ ® significantly increased the fluoroscopy time in the study of Wakili [24].…”
Section: Resultsmentioning
confidence: 81%
“…[21] 58 years for the PVAC ® group and 62 years for the conventional group, all p < 0.05), gender (except for the study by Looi et al. [20] 55% male for the PVAC ® group and 74% male for the conventional group, p < 0.05), duration of AF or episode numbers, baseline ejection fraction, or left atrial diameter (except for the study by Khaykin et al. [19] p = 0.03, see Table 2), where available.…”
Section: Resultsmentioning
confidence: 93%
See 2 more Smart Citations
“…In the AF population, QoL improves with treatment and improvement is associated with maintenance of NSR . For older patients, QoL has been shown to significantly decrease with increasing age and AF ablation has been shown to significantly improve the QoL in AF patients . Quantification of symptom improvement through assessment of health‐related QoL is a critical component in evaluating patient outcomes and clinical effectiveness of AF ablation .…”
Section: Discussionmentioning
confidence: 99%